Department of Medicine Archive — Page 56 of 120
-
November 18, 2021
Antimicrobial stewardship effort expanding reach
The Vanderbilt Antimicrobial Stewardship Program recently expanded to the outpatient realm to provide more support for providers to optimize antibiotic use and delivery in the clinic setting. -
November 15, 2021
Who’s who in the respiratory landscape
A metatranscriptomics method developed by Vanderbilt researchers simultaneously characterizes viruses, microbiome and host response in nasal swabs, opening opportunities to explore molecular interactions directly in clinical samples. -
November 11, 2021
VUMC team puts tool to reduce heart failure admissions to test
Vanderbilt researchers have developed a risk stratification tool to predict outcomes and avoid unnecessary hospital admissions after emergency department visits for acute heart failure. -
November 11, 2021
New way to bEET insulin resistance
Signaling molecules called EETs could improve insulin resistance, a primary risk factor for Type 2 diabetes and cardiovascular disease, Vanderbilt researchers have discovered. -
November 11, 2021
International gathering scrutinizes immune response, beta cell biology in Type 1 diabetes
-
November 4, 2021
Harrison Society researcher discovers key regulator of kidney cell structure
New research from Vanderbilt could aid efforts to promote kidney regeneration after injury or to develop engineered organs. -
November 2, 2021
Shifts in neuroendocrine cancer clinical trial design
Clinical trials that focus on specific types of neuroendocrine neoplasms — heterogeneous tumors that can occur anywhere in the body — will be more likely to enhance drug development for these tumors, Vanderbilt physicians assert.